Copyright
©The Author(s) 2022.
World J Clin Cases. Aug 16, 2022; 10(23): 8161-8169
Published online Aug 16, 2022. doi: 10.12998/wjcc.v10.i23.8161
Published online Aug 16, 2022. doi: 10.12998/wjcc.v10.i23.8161
Table 1 Intergroup comparison of age, gender, and number of comorbidities
| COVID-19 deceased patients | Critically ill group | Severe group | F/χ2 | P value | |
| Age | 71.50 ± 10.41 | 63.78 ± 11.58 | 65.59 ± 11.75 | 1.978 | 0.147 |
| Gender | 0.053 | 0.974 | |||
| Female | 6 | 12 | 13 | ||
| Male | 6 | 14 | 14 | ||
| Number of comorbidities | 4.251 | 0.119 | |||
| 0 | 3 | 12 | 8 | ||
| 1 | 3 | 9 | 6 | ||
| 2 | 3 | 2 | 8 | ||
| 3 | 1 | 2 | 5 | ||
| 4 | 2 | 1 | 0 |
- Citation: Wang L, Gao Y, Zhang ZJ, Pan CK, Wang Y, Zhu YC, Qi YP, Xie FJ, Du X, Li NN, Chen PF, Yue CS, Wu JH, Wang XT, Tang YJ, Lai QQ, Kang K. Comparison of demographic features and laboratory parameters between COVID-19 deceased patients and surviving severe and critically ill cases. World J Clin Cases 2022; 10(23): 8161-8169
- URL: https://www.wjgnet.com/2307-8960/full/v10/i23/8161.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v10.i23.8161